Insulin timing study for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how timing your insulin bolus (the extra insulin you take with meals) can improve blood sugar control. It involves adults with type 1 diabetes who are already using the MiniMed 780G pump with Novorapid insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had type 1 diabetes for at least 3 years.
- You must be between 18 and 70 years old.
- You must be using the MiniMed 780G insulin pump for at least 3 months.
- You must use Novorapid insulin in your pump for at least two weeks before the study.
- Your blood sugar should be in target range more than 70% of the time for the last 14 days.
- You need to count carbohydrates and use the pump's bolus calculator.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two methods for deciding how much insulin to take with meals: counting exact carbohydrates or using a simpler meal-size guide. It aims to see which approach works best for people with type 1 diabetes who already use multiple daily injections and have moderate to high blood sugar levels (HbA1c 7.5% to under 11%).
This study looks at how the number of meals you eat each day affects your blood sugar levels. If you have type 1 diabetes and manage your carbs, you might be able to join and learn more about your meal patterns.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study looks at whether turning off meal announcements in automated insulin delivery systems (which adjust insulin automatically) is safe and effective for people with type 1 diabetes. It may help simplify daily diabetes management.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial tests if a quick-acting glucagon nasal spray can prevent low blood sugar after meals in people with type 1 diabetes who use an automated insulin pump. If you count carbs and use NovoRapid or Fiasp insulin, this could help you avoid post-meal lows.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.